PRP vs Corticosteroid for Glenohumeral Osteoarthritis

Phase 3, randomised, single-blind trial of autologous platelet-rich plasma in glenohumeral osteoarthritis (3 arms), sponsored by Walter Reed National Military Medical Center. Primary endpoints: Single Assessment Numeric Evaluation at 24 months, American Shoulder and Elbow Surgeons Standardized Shoulder Form at 24 months and 4 more. Started Sep 2022; status: completed.